First Time Loading...
N

Nichi-Iko Pharmaceutical Co Ltd
TSE:4541

Watchlist Manager
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Watchlist
Price: 0.0001 JPY Market Closed
Updated: Apr 29, 2024

Nichi-Iko Pharmaceutical Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nichi-Iko Pharmaceutical Co Ltd
Operating Income Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Operating Income
-¥28.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Operating Income
¥464.9B
CAGR 3-Years
7%
CAGR 5-Years
18%
CAGR 10-Years
17%
Daiichi Sankyo Co Ltd
TSE:4568
Operating Income
¥188B
CAGR 3-Years
37%
CAGR 5-Years
19%
CAGR 10-Years
5%
Otsuka Holdings Co Ltd
TSE:4578
Operating Income
¥294.7B
CAGR 3-Years
13%
CAGR 5-Years
32%
CAGR 10-Years
3%
Chugai Pharmaceutical Co Ltd
TSE:4519
Operating Income
¥444.2B
CAGR 3-Years
14%
CAGR 5-Years
29%
CAGR 10-Years
19%
Astellas Pharma Inc
TSE:4503
Operating Income
¥142B
CAGR 3-Years
-5%
CAGR 5-Years
-12%
CAGR 10-Years
3%

See Also

What is Nichi-Iko Pharmaceutical Co Ltd's Operating Income?
Operating Income
-28.3B JPY

Based on the financial report for Mar 31, 2022, Nichi-Iko Pharmaceutical Co Ltd's Operating Income amounts to -28.3B JPY.